#Belantamab is being WITHDRAWN as a Rx for refractory multiple myeloma (accelerated approval in August 2020 off #DREAMM2).
#DREAMM3: Ph3,N=320, belanta vs Pom/Dex after ≥2 Rx.
- No PFS/OS benefit
- similar ORR
- Belanta had ophthalmologic AEs
#belantamab #dreamm2 #dreamm3 #mmsm #bcma #OncEd #oncology #MedMastodon #myeloma